BR112018000102A2 - composições e métodos para modular e/ou estimular respostas imunológicas em seres humanos e/ou animais - Google Patents

composições e métodos para modular e/ou estimular respostas imunológicas em seres humanos e/ou animais

Info

Publication number
BR112018000102A2
BR112018000102A2 BR112018000102A BR112018000102A BR112018000102A2 BR 112018000102 A2 BR112018000102 A2 BR 112018000102A2 BR 112018000102 A BR112018000102 A BR 112018000102A BR 112018000102 A BR112018000102 A BR 112018000102A BR 112018000102 A2 BR112018000102 A2 BR 112018000102A2
Authority
BR
Brazil
Prior art keywords
modulating
immune responses
humans
animals
compositions
Prior art date
Application number
BR112018000102A
Other languages
English (en)
Other versions
BR112018000102B1 (pt
Inventor
Castex Mathieu
Original Assignee
Danstar Ferment Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danstar Ferment Ag filed Critical Danstar Ferment Ag
Publication of BR112018000102A2 publication Critical patent/BR112018000102A2/pt
Publication of BR112018000102B1 publication Critical patent/BR112018000102B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

trata-se de uma composição que compreende polissacarídeos parietais de pelo menos uma espécie candida e polissacarídeos parietais de pelo menos uma espécie de levedura diferente. a composição pode ser usada na modulação e/ou no estímulo de respostas imunológicas em animal ou ser humano.
BR112018000102-3A 2015-07-09 2016-07-11 Composições e métodos para modular e/ou estimular respostas imunológicas em seres humanos e/ou animais BR112018000102B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15176029.5A EP3138573A1 (en) 2015-07-09 2015-07-09 Compositions and methods for stimulating immune responses in human and/or animal
EP15176029.5 2015-07-09
PCT/EP2016/066446 WO2017005936A1 (en) 2015-07-09 2016-07-11 Compositions and methods for modulating and/or stimulating immune responses in human and/or animal

Publications (2)

Publication Number Publication Date
BR112018000102A2 true BR112018000102A2 (pt) 2018-09-04
BR112018000102B1 BR112018000102B1 (pt) 2021-10-05

Family

ID=53776303

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018000102-3A BR112018000102B1 (pt) 2015-07-09 2016-07-11 Composições e métodos para modular e/ou estimular respostas imunológicas em seres humanos e/ou animais

Country Status (13)

Country Link
US (1) US11338023B2 (pt)
EP (2) EP3138573A1 (pt)
JP (2) JP7252758B2 (pt)
CN (1) CN107847536A (pt)
AU (1) AU2016289523B2 (pt)
BR (1) BR112018000102B1 (pt)
CA (1) CA2990530A1 (pt)
CL (1) CL2017003442A1 (pt)
DK (1) DK3319621T3 (pt)
ES (1) ES2953462T3 (pt)
HU (1) HUE063641T2 (pt)
PL (1) PL3319621T3 (pt)
WO (1) WO2017005936A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
WO2023220275A1 (en) * 2022-05-12 2023-11-16 Can Technologies, Inc. Compositions and methods for the treatment and prevention of coccidiosis infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506210A (en) * 1988-08-19 1996-04-09 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
FR2726284B1 (fr) 1994-10-31 1996-12-27 Inst Oenologie Produit biologique pour la stabilisation physico-chimique d'un vin
US6214337B1 (en) * 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
US20030235569A1 (en) 2002-06-18 2003-12-25 Ling Yuk Cheung Feed additives for chickens
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
JP2009203160A (ja) 2006-05-25 2009-09-10 Saihatsu Ko 抗ウィルス及び抗菌剤
ES2740353T3 (es) 2007-04-20 2020-02-05 Rymco Int Ag Mezcla de péptidos como estabilizador de vinos
CN102228138B (zh) * 2011-06-04 2013-01-16 内蒙古农业大学 一种反刍动物微生态添加剂及其制备工艺

Also Published As

Publication number Publication date
WO2017005936A1 (en) 2017-01-12
EP3319621B1 (en) 2023-06-07
AU2016289523A1 (en) 2018-01-18
JP7291749B2 (ja) 2023-06-15
DK3319621T3 (da) 2023-08-21
EP3138573A1 (en) 2017-03-08
CL2017003442A1 (es) 2018-07-13
WO2017005936A9 (en) 2017-03-09
CA2990530A1 (en) 2017-01-12
ES2953462T3 (es) 2023-11-13
PL3319621T3 (pl) 2023-10-09
JP7252758B2 (ja) 2023-04-05
JP2018522001A (ja) 2018-08-09
BR112018000102B1 (pt) 2021-10-05
US20180207248A1 (en) 2018-07-26
CN107847536A (zh) 2018-03-27
US11338023B2 (en) 2022-05-24
EP3319621A1 (en) 2018-05-16
JP2021183608A (ja) 2021-12-02
AU2016289523B2 (en) 2022-07-14
HUE063641T2 (hu) 2024-01-28

Similar Documents

Publication Publication Date Title
CL2018003582A1 (es) Composiciones para modular la expresión de c9orf72 (divisional solicitud 201702567)
CO2019006291A2 (es) Composiciones de aminoácidos y métodos de tratamiento de enfermedades hepáticas
MX2022008663A (es) Composiciones alergenicas mixtas y metodos de uso de las mismas.
GT201700184A (es) Nuevas proteínas específicas para pioverdina y pioquelina
BR112014026744A8 (pt) anticorpo isolado ou fragmento de anticorpo, composição de anticorpo ou composição de fragmento de anticorpo, uso de modulação imune, uso de pelo menos uma composição de anticorpo ou fragmento de anticorpo, dispositivo médico, formulação, kit, artigo de fabricação para uso farmacêutico humano, método para produzir um anticorpo ou fragmento, animal ou planta transgênica, e, anticorpo ou porção ou variante especificada.
PE20171076A1 (es) Composicion que contiene quitina y proteinas digeribles
BR112018007872A2 (pt) composição
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
BR112018016991A2 (pt) ração úmida para animais de estimação compreendendo um análogo de carne protéico tendo uma textura melhorada
BR112017024940A2 (pt) composições de óleo essencial e seu método
CL2019003670A1 (es) Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
MX2018005628A (es) Tratamientos de grasa acumulada con acido desoxicolico y sales del mismo.
BR112018004310A2 (pt) derivados de espinosina e método de preparação
BR112017007748A2 (pt) “composição farmacêutica, agente antialérgico, composição alimentar, composição cosmética, uso de um extrato, e, método para prevenir ou tratar uma doença alérgica
BR112015023025A2 (pt) composições antimicrobianas e métodos de uso relacionados
BR112018077068A2 (pt) ingredientes para alimento compreendendo células microbianas lisadas
MA46641A (fr) Méthodes et compositions permettant d'empêcher la transmission de maladies propagées par un vecteur
BR112017008211A2 (pt) método para inibir infecção de um patógeno fúngico, formulação tópica ou extrato celular ou vegetal e uso de uma formulação ou extrato celular ou vegetal
BR112018069682A2 (pt) métodos de tratamento para doenças colestáticas e fibróticas
BR112018000102A2 (pt) composições e métodos para modular e/ou estimular respostas imunológicas em seres humanos e/ou animais
BR112018071696A2 (pt) conjunto de cânula e de agulha
BR112017028590A2 (pt) novo lipolantipeptídeo bicíclico, preparação e uso como agente antimicrobiano
BR112017016388A2 (pt) cenicriviroc para o tratamento da fibrose
MX2017007295A (es) Modelo animal de ojo seco y metodos de uso de dichos animales.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/07/2016, OBSERVADAS AS CONDICOES LEGAIS.